DJIA 17,778.15 421.28 2.43%
NASDAQ 4,748.40 104.08 2.24%
S&P 500 2,061.23 48.34 2.40%
market minute promo

NxStage Medical (NASDAQ: NXTM)

18.28 0.24 (1.33%)

REAL-TIME: Last trade at

Extended Hours: $18.28 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

NXTM $18.28 1.33%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $18.25
Previous Close $18.04
Daily Range $18.00 - $18.59
52-Week Range $9.39 - $18.59
Market Cap $1.1B
P/E Ratio -45.09
Dividend (Yield) $0.00 (0.0%)
Volume 351,385
Average Daily Volume 546,264
Current FY EPS -$0.41

Sector

Healthcare

Industry

Healthcare Information Services

NxStage Medical (NXTM) Description

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Website: http://www.nxstage.com/

News & Commentary Rss Feed

Why NxStage Medical Inc. Stock Surged Higher

Medical device maker NxStage filters out the pessimists and rockets higher by as much as 13% after reporting better-than-expected third-quarter earnings results and lifting its full-year sales forecast.

Health Care Sector Update for 12/18/2014: CMRX,CTRV,OVAS,RWLK,NXTM

Health Care Sector Update for 12/18/2014: TTPH,AMDA,RWLK,NXTM

Insider Trading Alert - VYFC, CI And NXTM Traded By Insiders

Insider Trading Alert - THOR, NXTM And AAON Traded By Insiders

NxStage Medical (NXTM) Upgraded From Sell to Hold

NxStage Medical Unveils Streamline Express Dialyzer - Analyst Blog

NxStage Medical Unveils Streamline Express Dialyzer - Analyst Blog

Update: NxStage Medical Q3 2014 Earnings

How to Uncover Institutional Buying - Screen of the Week

NxStage Medical's (NXTM) CEO Jeff Burbank on Q3 2014 Results - Earnings Call Transcript

See More NXTM News...

NXTM's Top Competitors

NXTM $18.28 (1.33%)
Current stock: NXTM
MDT $74.63 (2.70%)
Current stock: MDT
COV $103.22 (1.94%)
Current stock: COV
BAX $74.07 (2.49%)
Current stock: BAX